Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Because adolescents are at higher risk of sexually transmitted infections (STIs), obstetrician–gynecologists should continue to follow standard guidelines for STI screening. They should advise adolescents who choose LARC methods to use male or female condoms consistently (dual method use) to decrease the risk of STIs, including human immunodeficiency virus (HIV). Obstetrician–gynecologists should counsel all sexually active adolescents who do not seek pregnancy on the range of reversible contraceptive methods, including LARC, and should help make these contraceptives readily accessible to them.

Read More

Factors associated with low-lying intrauterine devices: a cross-sectional ultrasound study in a cohort of African-American women

Factors associated with low-lying intrauterine devices: a cross-sectional ultrasound study in a cohort of African-American women

Women who are obese may benefit from additional counseling and closer follow-up after IUD placement. Future research is warranted to investigate IUD placement and possible IUD migration among women who are obese.

Read More

Chronic Systemic Toxicity Study of Copper Intrauterine Devices in Female Wistar Rats

Chronic Systemic Toxicity Study of Copper Intrauterine Devices in Female Wistar Rats

The aim of this study was to evaluate the chronic systemic and local toxicity of a copper intrauterine device in a rat model. These results obtained at different dosages and long-term implantation provide solid data confirming the safety of long-term use of Cu-IUDs. However, the elevated leucocyte levels found in this study warrant further investigation.

Includes lots of references to other studies.

Read More

Copper-7 intrauterine device (Gravigard). Report of experience.

Copper-7 intrauterine device (Gravigard). Report of experience.

“Compared with oral contraceptives copper IUDs have less severe side effects but less safety at the same time-especially for the younger fertile age group. Therefore they should be offered to young nulliparous women only for a limited period of time.”

Read More